XERS FY 2022 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena

XERSXeris Biopharma Holdings, Inc.

$960M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$110M+122.3% YoY

Gross Profit

$88M79.5% margin

Operating Income

-$82M-74.3% margin

Net Income

-$95M-85.9% margin

EPS (Diluted)

$-0.70

Cash Flow

Operating Cash Flow

-$103M

Free Cash Flow

-$103M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$345M

Total Liabilities

$299M

Stockholders' Equity

$45M

Cash & Equivalents

$122M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$110M	$50M	+122.3%
Gross Profit	$88M	$36M	+141.5%
Operating Income	-$82M	-$115M	+28.8%
Net Income	-$95M	-$123M	+22.9%